GA SB433 | 2019-2020 | Regular Session

Status

Spectrum: Partisan Bill (Republican 5-0)
Status: Introduced on February 24 2020 - 25% progression, died in committee
Action: 2020-02-25 - Senate Read and Referred
Pending: Senate Insurance and Labor Committee
Text: Latest bill text (Introduced) [PDF]

Summary

A BILL to be entitled an Act to amend Title 33 of the Official Code of Georgia Annotated, relating to insurance, so as to require disclosure of diabetes prescription drug pricing; to provide for a short title; to provide for legislative findings; to provide for definitions; to provide for a listing of diabetes prescription drugs; to provide for drug manufacturer and pharmacy benefits manager report forms and insurer pricing reports; to provide for certain other reports; to provide for penalties; to amend Chapter 1 of Title 10 of the Official Code of Georgia Annotated, relating to selling and other trade practices, so as to provide for penalties regarding unfair or deceptive practices in consumer transactions; to provide for related matters; to provide for an effective date and applicability; to repeal conflicting laws; and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

'Diabetes Drug Pricing Transparency Act of 2020'; disclosure of diabetes prescription drug pricing; require

Sponsors


History

DateChamberAction
2020-02-25SenateSenate Read and Referred
2020-02-24SenateSenate Hopper

Georgia State Sources


Bill Comments

feedback